The effect of a secretion-enhanced heavy chain on improving intein-based dual-vector co-delivery of a full-length factor VIII gene

Chinese Science Bulletin

Volumn 56, Issue 2, 2011, Pages 158-163

  Zhu, FuXiang ^a   Yang, ShuDe ^a   Liu, ZeLong ^a   Miao, Jing ^a   Qu, HuiGe ^a   Chi, XiaoYan ^a  

^a LUDONG UNIVERSITY   (China)

Author keywords

coagulation factor VIII; intein; mutant heavy chain; protein splicing; secretion

Indexed keywords

ADENO-ASSOCIATED VIRUS; ANIMALIA; EUKARYOTA; PARVOVIRUS;

EID: 78751538279     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-010-4244-7     Document Type: Article

References (20)

1. Mann K G. Biochemistry and physiology of blood coagulation. Thromb Haemost, 1999, 82: 165-174.
2. Dooriss K L, Denning G, Gangadharan B, et al. Comparison of factor VIII Transgenes bioengineered for improved expression in gene therapy of hemophilia A. Hum Gene Ther, 2009, 20: 465-478.
3. Miao H Z, Sirachainan N, Palme L, et al. Bioengineering of coagulation factor VIII for improved secretion. Blood, 2004, 103: 3412-3419.
4. Swaroop M, Moussalli M, Pipe S W, et al. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem, 1997, 272: 24121-24124.
5. Burton M, Nakai H, Colosi P, et al. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. Proc Natl Acad Sci USA, 1999, 96: 12725-12730.
6. Scallan C D, Liu T, Parker A E, et al. Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII. Blood, 2003, 102: 3919-3926.
7. Perler F B. The ins and outs of gene expression control. Nat Biotechnol, 2004; 22: 824-826.
8. Chen L X, Zhu F X, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther, 2007, 15: 1856-1862.
9. Zhu F X, Liu Z L, Chi X Y, et al. Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene. Sci China Life Sci, 2010, 53: 683-689.
10. Gnatenko D V, Saenko E L, Jesty J, et al. Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapy. Br J Haematol, 1999, 104: 27-36.
11. Sarkar R, Tetreault R, Gao G, et al. Total correction of hemophiliaAmice with canine FVIII using anAAV 8 serotype. Blood, 2004, 103: 1253-1260.
12. Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell, 2006, 124: 587-599.
13. Kaufman R J, Pipe S W, Tagliavacca L, et al. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul Fibrinolysis, 1997, 8(Suppl 2): S3-S14.
14. Pipe S W. Coagulation factors with improved properties for hemophilia gene therapy. Semin Thromb Hemost, 2004, 30: 227-237.
15. Cunningham M A, Pipe S W, Zhang B, et al. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J Thromb Haemost, 2003, 1: 2360-2367.
16. Dorner A J, Wasley L C, Kaufman R J. Protein dissociation from GRP78 and secretion are blocked by depletion of cellular ATP levels. Proc Natl Acad Sci USA, 1990, 87: 7429-7432.
17. Pittman D D, Tomkinson K N, Kaufman R J. Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells. J Biol Chem, 1994, 269: 17329-17337.
18. Gimble F S. Putting protein splicing to work. Chem Biol, 1998, 5: R251-R256.
19. Cheriyan M, Perler F B. Protein splicing: A versatile tool for drug discovery. Adv Drug Deliv Rev, 2009, 61: 899-907.
20. Zhu F X, Yang S D, Liu Z L, et al. vWF improves secretion and activity of intein spliced BDD-FVIII (in Chinese). Acta Pharm Sin, 2010, 45: 595-600.